Anti-RANKL antibody was approved for the treatment of osteoporosis in Japan.

Yasuda, Hisataka

Anti-RANKL antibody was approved for the treatment of osteoporosis in Japan. [electronic resource] - Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology 2013 - 209-16 p. digital

Publication Type: Journal Article; Review

1349-7413

10.2177/jsci.36.209 doi


Animals
Antibodies, Monoclonal, Humanized--therapeutic use
Denosumab
Humans
Osteoclasts--drug effects
Osteoporosis--drug therapy
RANK Ligand--immunology